Intrinsic Resistance Patterns
A student guide to natural resistance patterns that are expected for an organism group and should not be treated as surprising acquired resistance.
Core idea
Intrinsic resistance prevents students from memorizing impossible drug-organism pairings and helps explain why some agents are not reported for certain organisms.
Principle
Intrinsic resistance comes from normal organism biology: missing targets, impermeable envelopes, inactive uptake pathways, natural enzymes, or metabolism that does not support the drug effect.
Natural Resistance Logic
| Pattern to remember | Underlying idea | Student warning |
|---|---|---|
| Anaerobes and aminoglycosides | Drug uptake is poor without oxidative metabolism | Do not expect aminoglycosides to work as standalone anaerobe therapy |
| Gram-negative organisms and vancomycin | Outer membrane blocks effective access to the target | Vancomycin is not a Gram-negative rod solution |
| Gram-positive organisms and aztreonam | The target profile does not match useful activity | Aztreonam is mainly a Gram-negative aerobic rod concept |
| Enterococci and many cephalosporins | Binding targets are not effectively inhibited | Cephalosporin activity against enterococci is unreliable |
| Klebsiella group and ampicillin | Natural beta-lactamase activity can inactivate ampicillin | Ampicillin resistance is expected for many Klebsiella isolates |
| Aerobes and metronidazole | The drug requires anaerobic reduction for activity | Metronidazole is not an aerobic bacteriology catch-all |
| Lactobacillus or Leuconostoc and vancomycin | Cell-wall target biology can make vancomycin ineffective | These genera can surprise students if treated like routine Gram positives |
| Stenotrophomonas maltophilia and carbapenems | Intrinsic beta-lactamase activity and permeability patterns limit carbapenems | Carbapenem resistance is part of the organism story |
Exact testing and reporting depend on current standards and local laboratory policy.
Expanded Intrinsic Resistance Examples
| Organism/group | Natural resistance pattern | Mechanism idea | Study warning |
|---|---|---|---|
| Anaerobes | Aminoglycosides | Poor uptake without oxidative metabolism | Aminoglycosides are not standalone anaerobe drugs |
| Gram-negative rods | Vancomycin | Outer membrane prevents useful access | Vancomycin is a Gram-positive concept in routine bacteriology |
| Gram-positive organisms | Aztreonam | Drug target/spectrum does not fit | Do not apply aztreonam broadly just because it is a beta-lactam |
| Enterococcus spp. | Cephalosporins | PBPs are not effectively inhibited | Cephalosporin activity is unreliable even if the panel seems tempting |
| Klebsiella spp. | Ampicillin | Natural beta-lactamase activity | Ampicillin resistance is expected |
| Aerobic bacteria | Metronidazole | Drug activation favors anaerobic conditions | Metronidazole is not a general aerobic bacterial drug |
| Lactobacillus/Leuconostoc/Pediococcus-like organisms | Vancomycin | Cell-wall target biology creates poor activity | Intrinsic resistance can mimic an alarming acquired phenotype |
| Stenotrophomonas maltophilia | Carbapenems and many beta-lactams | Intrinsic beta-lactamases and permeability patterns | Carbapenem resistance is part of the organism identity |
| Pseudomonas aeruginosa | Many narrow agents | Low permeability and efflux-prone envelope | Choose organism-appropriate anti-pseudomonal agents |
| Mycoplasma/Ureaplasma | Cell-wall active drugs | No classic peptidoglycan cell wall | Beta-lactams do not fit organisms without the target |
Basic workflow
- Identify the organism group before judging the drug result.
- Ask whether the drug can enter, bind, or become active in that organism.
- Separate expected natural resistance from acquired resistance that has clinical or infection control meaning.
- Use AST rules and laboratory reporting logic to decide what should be tested or suppressed.
- Avoid interpreting a drug result when the organism-drug pair is not meaningful.
How to read it
- Anaerobes are naturally poor targets for aminoglycosides because uptake depends on oxidative metabolism.
- Large glycopeptides such as vancomycin do not effectively reach targets in many Gram-negative organisms.
- Some organisms naturally produce enzymes or have targets that make selected drugs unreliable.
- Intrinsic resistance is a reason to know the organism before trusting a panel.
High-yield trapCommon mistakes
- Calling expected resistance a new mechanism.
- Forgetting that a reported category can be suppressed by lab rules.
- Memorizing a resistance fact without knowing the biological reason.
ShortcutStudent shortcut
If a drug seems pointless for a group, ask whether it can get in, find a target, or become active.